Eli Lilly has a broad pipeline of weight-loss products that will help it maintain its lead in this a

A pullback in the AI trade has created opportunities for bargain-hunting investors, according to ana

Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, w

In the Large-Cap Pharmaceuticals industry, LLY, J&J and BAYRY are worth watching as the industry sho

Fidelity's lower 0.08% fee and broader 338-stock portfolio contrast sharply with iShares' concentrat

Active management and a charitable mission drive Simplify's 42% gain, but iShares offers lower costs

Novo Nordisk CEO Mike Doustdar said investors are underestimating the demand for differentiation amo

Novo Nordisk CEO Mike Doustdar defended the drugmaker's decision to sue rival Eli Lilly over its wei

I underestimated Eli Lilly and Company. LLY's Retatrutide showed promising efficacy in TRIUMPH-2/TRI

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness

Eli Lilly has filed six new lawsuits against U.S. entities that it alleges are selling a version of

Eli Lilly on Wednesday said it ‌had filed six lawsuits against U.S. companies it accuses of illegall

Files six new lawsuits as company escalates fight to protect patients INDIANAPOLIS, Aug. 12, 2026 /P

Eli Lilly (NYSE:LLY | LLY Price Prediction) delivered a monster quarter with revenue growth, a fourt

This market has a population of almost 60 million. While the drug isn't the first of its type to be

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

Investors are still skittish enough that they only want to buy proven winners, so backing the favori

Eli Lilly and Company NYSE: LLY reported 48% revenue growth in the second quarter of 2026, driven pr

Eli Lilly should request approval for retatrutide early next year. This medicine could help the comp

Eli Lilly and Company delivered a monumental Q2 2026, with revenues up 48% to $23 billion, driven by

The ETF market saw a massive surge into core index heavyweights this past week, as investors poured

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil

Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new fede

Eli Lilly's latest results made investors happy, as the stock jumped 5% on their release, as both re

A Dutch court has banned sales of an unapproved compounded semaglutide nasal spray following a legal

Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 m

The CNN Money Fear and Greed index showed improvement in market sentiment on Wednesday, while Dow Jo

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Extreme Positive Sentiment Please click here for an enlarged chart of SPDR S&P 500 ETF Tr

Stocks mixed as Nasdaq falls 100 points, Dow rises .79%. Eli Lilly beats earnings estimates, Digital

CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.New colla

Polymarket traders see more upside after the S&P 500 hit a record high on strong earnings and ho

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on poten

Earnings coming Wed with varying volatility levels. Benzinga Pro selected list incl. relatively mute

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Earnings season is approaching, and Benzinga Pro has a list of top stocks to watch. Gilead Sciences

SanDisk, Western Digital and eight other names carry the biggest implied earnings moves in the first

Jim Cramer likes Ross Stores (ROST) on CNBC's Mad Money Lightning Round. Ross Stores reported st

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Eli Lilly reports positive Phase 3 data for retatrutide, showing major weight loss in adults. US reg

Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), t

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging false advertising and deceptive marketi

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Li

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are

UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp d

GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea

Lilly will acquire AtaiBeckley in a deal worth up to $3.8 billion, adding late-stage depression ther

The developer of the world’s first end-to-end AI drug has projected a big leap in half-year earnings

U.S. stock futures declined on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices fell,